Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A healthy Europe through data, information and cooperation.

Journal of health monitoring·2025
Same author

Towards a sustainable set of European Core Health Indicators (ECHI).

Journal of health monitoring·2025
Same author

Towards a European health information system: The BRIDGE Health, InfAct and PHIRI projects.

Journal of health monitoring·2025
Same author

Surveillance of non-communicable diseases: What matters to users? A qualitative interview study.

Journal of health monitoring·2025
Same author

Diabetes surveillance - Laying the groundwork for non-communicable disease surveillance in Germany.

Journal of health monitoring·2024
Same author

Corrigendum: Health in Germany: Establishment of a population-based health panel.

Journal of health monitoring·2024
Same journal

Plexin A2 regulated the metastasis in breast cancer through MCM7.

BMC cancer·2026
Same journal

Spatial profiling of tissue-resident memory T cells reveals stromal IL-15 niches and a paradoxical CD103⁺ phenotype predicting survival in oral squamous cell carcinoma.

BMC cancer·2026
Same journal

Epidemiological trends of non-small cell lung cancer and systemic treatment rates as part of initial therapeutic strategy from 2016 to 2020 in Greece: results of the epidemiological part of INFINITY study.

BMC cancer·2026
Same journal

Multi-level stakeholder perspectives on barriers and facilitators to engaging older adult cancer survivors in mental health treatment.

BMC cancer·2026
Same journal

Preliminary study on the mechanism of OPN up-regulating PD-L1 to induce CD8 + T cell exhaustion in synovial sarcoma.

BMC cancer·2026
Same journal

Benefits and challenges of adding BKM120 to a BI-3406 plus trametinib combination therapy.

BMC cancer·2026
See all related articles

Related Experiment Video

Updated: Jun 16, 2026

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
08:08

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

Published on: February 27, 2015

German cancer statistics 2004.

Jörg Haberland1, Joachim Bertz, Ute Wolf

  • 1Robert Koch Institute, Department of Epidemiology and Health Reporting, Papestrasse 62-66, 12101 Berlin, Germany. haberlandj@rki.de

BMC Cancer
|February 24, 2010
PubMed
Summary
This summary is machine-generated.

Cancer incidence in Germany is high, with over 436,000 new cases in 2004. Lifetime cancer risk is substantial for both men and women, highlighting the importance of cancer registries for tracking disease trends.

Related Experiment Videos

Last Updated: Jun 16, 2026

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
08:08

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

Published on: February 27, 2015

Area of Science:

  • Oncology
  • Epidemiology
  • Public Health

Background:

  • The Robert Koch Institute (RKI) annually compiles data from German population-based cancer registries and cause-of-death statistics.
  • Traditionally, RKI estimates new cancer cases in Germany using available regional registry data for key indicator development.

Purpose of the Study:

  • To provide an overview of current cancer indicators in Germany, including incidence, prevalence, mortality, and survival rates.
  • To present updated statistics on the most common cancer types and associated risks of developing and dying from cancer.

Main Methods:

  • Review and evaluation of data from German population-based cancer registries.
  • Analysis of cause-of-death statistics from statistical offices.
  • Estimation of cancer incidence, prevalence, and mortality risks at the federal level.

Main Results:

  • In 2004, an estimated 436,500 new cancer cases occurred in Germany.
  • Prostate cancer (men) and breast cancer (women) are the most common, followed by colorectal and lung cancer.
  • Lifetime cancer risk is 48.5% for men and 40.3% for women; approximately one in four men and one in five women die from cancer.

Conclusions:

  • Population-based cancer registration in Germany is approaching complete nationwide coverage.
  • Continuous improvements in data quality enhance the understanding of cancer development in Germany.